Nuvation Bio Inc experienced a rather shaky stock market performance.
52-week price history of NUVB Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Nuvation Bio Inc’s current trading price is -37.80% away from its 52-week high, while its distance from the 52-week low is 60.34%. The stock’s price range during this period has spanned from $1.54 to $3.97. In the Healthcare sector, the Nuvation Bio Inc’s shares surpassed a trading volume of approximately 1.48 million for the day, which was noticeably lower compared to the average daily volume of 9.3.66 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Nuvation Bio Inc (NUVB) has experienced a quarterly rise of 10.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 840.18M and boasts a workforce of 220 employees.
Making Sense of Trading Volume and Moving Average Data
Examining NUVB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for NUVB stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.
NUVB Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -7.17%.However, over the last six months, we can see a stronger performance of -13.36%. Over the last 30 days, the price of NUVB has fallen by 14.85%. And in the last five days, it has surged by 0.78%.
